Prevalence of depression in a 12-month consecutive sample of patients with ALS

European Journal of Neurology

Volumn 14, Issue 9, 2007, Pages 993-1001

  Wicks, P ^a   Abrahams, S ^b   Masi, D ^a   Hejda Forde, S ^a   Leigh, P N ^a   Goldstein, L H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Anxiety; Depression; Motor neurone disease; Prevalence study

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; RILUZOLE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; COMPARATIVE STUDY; DEPRESSION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OUTPATIENT DEPARTMENT; PREVALENCE; PRIORITY JOURNAL; SAMPLE; STATE TRAIT ANXIETY INVENTORY; TERTIARY HEALTH CARE; UNITED KINGDOM;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; STATISTICS; STATISTICS, NONPARAMETRIC;

EID: 34548132496     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01843.x     Document Type: Article

References (55)

1. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999 52 : 504 509.
2. Turner MR, Parton MJ, Shaw CE, Leigh PN, Al Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. Journal of Neurology Neurosurgery and Psychiatry 2003 74 : 995 997.
3. Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neurone disease. Journal of the Neurological Sciences 1998 160 (Suppl. 1 S53 S56.
4. Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosomatic Medicine 2000 62 : 271 279.
5. Brown WA, Mueller PS. Psychological function in individuals with amyotrophic lateral sclerosis. Psychosomatic Medicine 1970 32 : 141 152.
6. Peters PK, Swenson WM, Mulder DW. Is there a characteristic personality profile in amyotrophic lateral sclerosis? A Minnesota multiphasic personality inventory study. Archives of Neurology 1978 35 : 321 322.
7. Hunter MD, Robinson IC, Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation. Disability and Rehabilitation 1993 15 : 119 126.
8. Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology 1999 52 : 1434 1440.
9. Beck AT, Ward C, Mendelson M. Beck depression inventory (BDI). Archives of General Psychiatry 1961 4 : 561 571.
10. Tedman B, Young C, Williams I. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. Journal of the Neurological Sciences 1997 152 (Suppl. 1 S75 S79.
11. Trail M, Nelson ND, Van JN, Appel SH, Lai EC. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. Journal of the Neurological Sciences 2003 209 : 79 85.
12. Rabkin JG, Albert SM, Del Bene ML, O'Sullivan I, Tider T, Rowland LP, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005 65 : 62 67.
13. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003 61 : 1524 1527.
14. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biological Psychiatry 2003 54 : 363 375.
15. Jackson MJ, Turkington D. Depression and anxiety in epilepsy. Journal of Neurology Neurosurgery and Psychiatry 2005 76 (Suppl. 1 i45 i47.
16. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biological Psychiatry 2003 54 : 376 387.
17. Peyser CE, Folstein SE. Huntington's disease as a model for mood disorders. Clues from neuropathology and neurochemistry. Molecular and Chemical Neuropathology 1990 12 : 99 119.
18. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology 2001 10 : 19 28.
19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983 67 : 361 370.
20. Zarate CA, Payne JL, Quiroz J, Sporn J, Denicoff KK, Luckenbaugh D, et al. An open-label trial of riluzole in patients with treatment-resistant major depression. American Journal of Psychiatry 2004 161 : 171 174.
21. Sanacora G, Kendell SF, Levin Y, Simen AA, Fenton LR, Coric V, et al. Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biological Psychiatry 2006 15 : 822 825.
22. Brooks B, Miller R, Swash M, Munsat L. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000 1 : 293 299.
23. Jefferies K, Owino A, Rickards H, Agrawal N. Psychiatric disorders in neurology inpatients: estimate of prevalence and usefulness of screening questionnaires. Journal of Neurology Neurosurgery and Psychiatry 2006 78 : 414 416.
24. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Spielberger State-Trait Anxiety Inventory. California : Mind Garden, 1968, 1977.
25. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory, 2nd edn. The Psychological Corporation : San Antonion, Texas, 1996.
26. Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical sample. British Journal of Clinical Psychology 2001 40 : 429 434.
27. Kvaal K, Laake K, Engedal K. Psychometric properties of the state part of the Spielberger State-Trait Anxiety Inventory (STAI) in geriatric patients. International Journal of Geriatric Psychiatry 2001 16 : 980 986.
28. Lisspers J, Nygren A, Soderman E. Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Neurologica Scandinavica 1997 96 : 281 286.
29. Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. Journal of Neurology Neurosurgery and Psychiatry 1992 55 : 1106 1115.
30. Watson DE, Heppner P, Roos NP, Reid RJ, Katz A. Population-based use of mental health services and patterns of delivery among family physicians, 1992 to 2001. Canadian Journal of Psychiatry 2005 50 : 398 406.
31. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck depression inventory for primary care. Behaviour Research and Therapy 1997 35 : 785 791.
32. Ganzini L, Johnston W, McFarland B, Tolle S, Lee M. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide. New England Journal of Medicine 1998 339 : 967 973.
33. Bowling A. Mode of questionnaire administration can have serious effects on data quality. Journal of Public Health 2005 27 : 281 291.
34. Lieberman A. Depression in Parkinson's disease - a review. Acta Neurologica Scandinavica 2006 113 : 1 8.
35. Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. Journal of Neuroimaging 2004 14 (Suppl. 3 36S 45S.
36. Abrahams S, Goldstein LH, Suckling J, Simmons A, Ng V, Giampietro V, et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. Journal of Neurology 2005 252 : 321 331.
37. Turner MR, Rabiner EA, Hammers A, Al-Chalabi A, Grasby PM, Shaw CE, et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 2005 128 (Pt 4 896 905.
38. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, et al. PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 1999 46 : 1375 1387.
39. Lule D, Kurt A, Jurgens R, Kassubek J, Diekmann V, Kraft E, et al. Emotional responding in amyotrophic lateral sclerosis. Journal of Neurology 2005 252 : 1517 1524.
40. Papps B, Abrahams S, Wicks P, Leigh PN, Goldstein LH. Changes in memory for emotional material in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2005 43 : 1107 1114.
41. Iannaccone S, Ferini-Strambi L. Pharmacologic treatment of emotional lability. Clinical Neuropharmacology 1996 19 : 532 535.
42. Kubler A, Winter S, Ludolph AC, Hautzinger M, Birbaumer N. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabilitation and Neural Repair 2005 19 : 182 193.
43. Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychological Medicine 1994 24 : 625 632.
44. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III). Journal of the Neurological Sciences 1999 169 : 13 21.
45. Montes J, Levy G, Albert S, Kaufmann P, Buchsbaum R, Gordon PH, et al. Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 2006 67 : 1294 1296.
46. Watson D, Weber K, Assenheimer JS, Clark LA, Strauss ME, McCormick RA. Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. Journal of Abnormal Psychology 1995 104 : 3 14.
47. Moriarty J. Psychiatric disorders in neurology patients. Journal of Neurology Neurosurgery and Psychiatry 2006 78 : 331.
48. Clarke DM, McLeod JE, Smith GC, Trauer T, Kissane DW. A comparison of psychosocial and physical functioning in patients with motor neurone disease and metastatic cancer. Journal of Palliative Care 2005 21 : 173 179.
49. McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis. The role of psychological factors. Archives of Neurology 1994 51 : 17 23.
50. Johnston M, Earll L, Giles M, McClenahan R, Stevens D, Morrison V. Mood as a predictor of disability and survival in patients newly diagnosed with ALS/MND. British Journal of Health Psychology 1999 4 : 127 136.
51. Rabkin JG, Albert SM, Tider T, Del Bene ML, O'Sullivan I, Rowland LP, et al. Predictors and course of elective long-term mechanical ventilation: a prospective study of ALS patients. Amyotrophic Lateral Sclerosis 2006 7 : 86 95.
52. Kendrick T, King F, Albertella L, Smith PW. GP treatment decisions for patients with depression: an observational study. British Journal of General Practice 2005 55 : 280 286.
53. Fink P, Hansen MS, Sondergaard L, Frydenberg M. Mental illness in new neurological patients. Journal of Neurology Neurosurgery and Psychiatry 2003 74 : 817 819.
54. Grossman AB, Levin BE, Bradley WG. Premorbid personality characteristics of patients with ALS. Amyotrophic Lateral Sclerosis 2006 7 : 27 31.
55. Goldstein LH, Adamson M, Jeffrey L, Down K, Barby T, Wilson C, et al. The psychological impact of MND on patients and carers. Journal of the Neurological Sciences 1998 160 (Suppl. 1 S114 S121.